Delivery Order SPE2DB20D2014-SPE2DB25FB63L
Award Date
4/15/25
Potential Completion Date
4/16/25
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DX22D0010|SPE2D825FFL06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $48,794.80 firm fixed-price delivery order is for the supply of 4,568,136,457 units of the medication Vyvanse (40mg capsules). The contract has an ultimate completion date of May 6, 2025 and was awarded on May 5, 2025. This delivery order is part of Amerisourcebergen's larger...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FEBRF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,518.70 firm fixed-price delivery order is for 4,568,076,830 units of the prescription medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 30, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,809.54 firm-fixed-price delivery order is for 4,556,517,806 units of the medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of March 10, 2022 and was awarded on March 9, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,453.36 firm fixed-price delivery order is for the supply of 4,566,490,419 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FY2NZ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,833.58 firm fixed-price delivery order is for the supply of 4,567,781,802 units of the medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVF56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vyvanse 30 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a delivery order with a firm fixed price, valued at $3,399.45. It has an ultimate completion date of April 11, 2025. The contract...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FY3QY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,536.64 firm fixed-price delivery order is for the supply of 4,568,000 units of the 40mg capsule formulation of the medication Vyvanse. The contract has an ultimate completion date of April 23, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,783.60 firm-fixed-price delivery order is for the supply of 100 capsules of the prescription drug Vyvanse 30 mg. The contract has a period of performance through December 16, 2024 and was awarded on December 13, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a $6,261.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 100 units of the drug Vyvanse 30 mg capsules. The contract has a period of performance ending on May 23, 2025. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.70 firm fixed-price delivery order is for the supply of 4,566,670,914 units of the prescription medication Vyvanse 20 mg capsules. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract...